Clinical potential of inclisiran for patients with a high risk of atherosclerotic cardiovascular disease

Elevated low-density lipoprotein cholesterol (LDL-C) level is associated with an increased risk of atherosclerotic cardiovascular disease. Although high-intensity lipid-lowering therapies with statins and ezetimibe are highly effective for reducing LDL-C levels, over half of high-risk patients do no...

Descripción completa

Detalles Bibliográficos
Autor principal: Nishikido, Toshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887852/
https://www.ncbi.nlm.nih.gov/pubmed/36717882
http://dx.doi.org/10.1186/s12933-023-01752-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887852/
https://www.ncbi.nlm.nih.gov/pubmed/36717882
http://dx.doi.org/10.1186/s12933-023-01752-4

Ejemplares similares